Abstract
Cytosolic class 3 aldehyde dehydrogenase (ALDH-3) is a demonstrated determinant of cellular sensitivity to the cytotoxic action of certain widely used antineoplastic prodrugs collectively referred to as oxazaphosphorines, e.g., cyclophosphamide, ifosfamide, 4-hydroperoxycyclophosphamide, 4-hydroperoxyifosfamide and mafosfamide (cellular sensitivity to these drugs decreases as cellular levels of ALDH-3 increase) (Sladek, 1993; Sreerama and Sladek, 1993a,b, 1994; Bunting et al., 1994; Rekha et al., 1994; Sladek et al., 1995; Sreerama et al., 1995; Bunting and Townsend, 1996). Thus, tumor cells, otherwise sensitive to the oxazaphosphorines, became resistant to these drugs when electroporated with purified ALDH-3 protein or transfected with the cDNA coding for ALDH-3 (Bunting et al., 1994; Sreerama and Sladek, 1995; Bunting and Townsend, 1996), and, of therapeutic significance, relatively elevated levels of this enzyme can account for intrinsic, transient acquired, and stable acquired, resistance to the oxazaphosphorines on the part of malignant cells (Sreerama and Sladek, 1993a,b, 1994; Rekha et al., 1994; Sreerama et al., 1995). Resistance to the oxazaphosphorines mediated by ALDH-3 is ostensibly due to the enzyme-catalyzed oxidative detoxification of aldophosphamide, the pivotal metabolite of these prodrugs (Sreerama and Sladek, 1993a, 1994; Rekha et al., 1994; Sreerama et al., 1995; Bunting and Townsend, 1996).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Band, V., Hoffer, A.P., Band, H., Rhinehardt, A.E., Knapp, R.C., Matlin, S.A. and Anderson, D.J.: Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol. Oncol. 32 (1989) 273–277.
Benz, C.C., Keniry, M.A., Ford, J.M., Townsend, A.J., Cox, F.W., Palayoor, S., Matlin, S.A., Hait, W.N. and Cowan, K.H.: Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol. Pharmacol. 37 (1990) 840–847.
Bunting, K.D. and Townsend, A.J.: Protection by transfected rat or human class 3 aldehyde dehydrogenases against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. J. Biol. Chem. 271 (1996) 11891–11896.
Bunting, K.D., Lindahl, R. and Townsend, A.J.: Oxazaphosphorine-specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J. Biol. Chem. 269 (1994) 23197–23203.
Burgos, C., Gerez de Burgos, N.M., Rovai, L.E. and Blanco, A.: In vitro inhibition by gossypol of oxidoreductases from human tissues. Biochem. Pharmacol. 35 (1986) 801–804.
Chang, C.J.G., Ghosh, P.K., Hu, Y.F., Brueggemeier, R.W. and Lin, Y.C.: Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Res. Commun. Chem. Pathol. Pharmacol. 79 (1993) 293–312.
Chueh, S.-H., Chang, G.-G., Chang, T.-C. and Pan, F.: Involvement of arginine residue in the phosphate binding site of human placental alkaline phosphatase. Int. J. Biochem. 13 (1981) 1143–1149.
Coyle, T., Levante, S., Shetler, M. and Winfield, J.: In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines. J. Neurooncol. 19 (1994) 25–35.
Deck, L.M., Vander Jagt, D.L., Royer, R.E.: Gossypol and Derivatives: a new class of aldose reductase inhibitors. J. Med. Chem. 34 (1991) 3301–3305.
Den Boer, P.J. and Grootegoed, J.A.: Differential effects of (+)-and (-)-gossypol enantiomers on LDH-C4 activity of hamster spermatogenic epithelium in vitro. J. Reprod. Fertil. 83 (1988) 701–709.
Dockham, P.A., Lee, M.-O. and Sladek, N.E.: Identification of human aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 43 (1992) 2453–2469.
FDA: Food drug cosmetic law. 56 (1974) 518.94, 172.894.
Feldman, R.I. and Weiner, H.: Horse liver aldehyde dehydrogenase. II. Kinetics and mechanistic implications of the dehydrogenase and esterase activity. J. Biol. Chem. 247 (1972) 267–272.
Flack, M.R., Pyle, R.G., Mullen, N.M., Lorenzo, B., Wu, Y.W., Knazek, R.A., Nisula, B.C. and Reidenberg, M.M.: Oral gossypol in the treatment of metastatic adrenal cancer. J. Clin. Endocrinol. Metab. 76 (1993) 1019–1024.
Ford, J.M., Hait, W.N., Matlin, S.A. and Benz, C.C.: Modulation of resistance to alkylating agents in cancer cell by gossypol enantiomers. Cancer Lett. 56 (1991) 85–94.
Gilbert, N.E., O’Reilly, J.E., Chang, C.J.G., Lin, Y.C. and Brueggemeier, R.W.: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci. 57 (1995) 61–67.
Hu, Y.-F., Chang, C.J.G., Brueggemeier, R.W. and Lin, Y.C.: Gossypol inhibits basal and estrogen-stimulated DNA synthesis in human breast carcinoma cells. Life Sci. 53 (1993) 433–438.
Hu, Y.-F., Chang, C.J.G., Brueggemeier, R.W. and Lin, Y.C.: Presence of antitumor activities in the milk collected from gossypol-treated dairy cows. Cancer Lett. 87 (1994) 17–23.
Ikeda, M.: Inhibition kinetics of NAD-linked enzymes by gossypol acetic acid. Andrologia 22 (1990) 409–416.
Joseph, A.E.A., Matlin, S.A. and Knox, P.: Cytotoxicity of enantiomers of gossypol. Br. J. Cancer 54 (1986) 511–513.
Kim, I.C., Waller, D.P. and Fong, H.H.S.: Inhibition of LDH-X by gossypol optical isomers. J. Androl. 6 (1985) 344–347.
Lambeir, A.-M., Loiseau, A.M., Kuntz, D.A., Vellieux, F.M., Michels, P.A.M. and Opperdoes, F.R.: The cytosolic and glycosomal glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma brucei. Kinetic properties and comparison with homologous enzymes. Eur. J. Biochem. 198 (1991) 429–435.
Lee, C.-Y.G., Moon, Y.S., Yuan, J.H., and Chen, A.F.: Enzyme inactivation and inhibition by gossypol. Mol. Cell. Biochem. 47 (1982) 65–70.
Messiha, F.S.: Effect of gossypol on kinetics of mouse liver alcohol and aldehyde dehydrogenase. Gen. Pharmacol. 22 (1991a) 573–576.
Messiha, F.S.: Behavioral and metabolic interaction between gossypol and ethanol. Toxicol. Lett. 57 (1991b) 175–181.
Moh, P.P., Chang, G.C.J., Brueggemeier, R.W. and Lin, Y.C.: Effect of gossypol on 5α-reductase and 3α-hydroxysteroid dehydrogenase activites in adult rat testes. Res. Comm. Chem. Pathol. Pharmacol. 82 (1993) 12–26.
Montamat, E.E., Burgos, C., Gerez de Burgos, N.M., Rovai, L.E. and Blanco, A.: Inhibitory action of gossypol on enzymes and growth of Trypanosoma cruzi. Science 218 (1982) 288–289.
Moreb, J., Schweder, M., Suresh, A. and Zucali, J.R.: Overexpression of the human aldehyde dehydrogenase class I results in increased resistance to 4-hydroperoxycyclophosphamide. Cancer Gene Ther. 3 (1996) 24–30.
Morris, I.D., Higgins, C. and Matlin, S.A.: Inhibition of testicular LDH-X from laboratory animals and man by gossypol and its isomers. J. Reprod. Fertil. 77 (1986) 607–612.
Naik, H.R., Petrylak, D., Yagoda, A., Lehr, J.E., Akhtar, A. and Pienta, K.J.: Preclinical studies of gossypol in prostate carcinoma. Int. J. Oncol. 6 (1995) 209–213.
Nakadate, T., Jeng, A.Y. and Blumberg, P.M.: Comparison of protein kinase C functional assays to clarify mechanisms of inhibitor action. Biochem. Pharmacol. 37 (1988) 1541–1545.
Olgiati, K.L. and Toscano, W.A. Jr.: Kinetics of gossypol inhibition of bovine lactate dehydrogenase X. Biochem. Biophys. Res. Commun. 115 (1983) 180–185.
Olgiati, K.L., Toscano, D.G., Atkins, W.M. and Toscano, W.A. Jr.: Gossypol inhibition of adenylate cyclase. Arch. Biochem. Biophys. 231(1984) 411–415.
Rekha, G.K., Sreerama, L. and Sladek, N.E.: Intrinsic cellular resistance to oxazaphosphorines exhibited by a human colon carcinoma cell line expressing relatively large amounts of a class-3 aldehyde dehydrogenase. Biochem. Pharmacol. 48 (1994) 1943–1952.
Rosenberg, L.J., Adlakha, R.C., Desai, D.M. and Rao, P.N.: Inhibition of DNA polymerase a by gossypol. Biochim. Biophys. Acta 866 (1986) 258–267.
Royer, R.E., Mills, R.G., Deck, L.M., Mertz, G.J. and Vander Jagt, D.L.: Inhibition of human immunodeficiency virus type I replication by derivatives of gossypol. Pharmcol. Res. 24 (1991) 407–412.
Sambrook, J., Fritsch, E.F. and Maniatis, T.: Preparation and transformation of competent E. coli. In Molecular Cloning. A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, 1989, pp. 1.74–1.84.
Sang, G.W., Lorenzo, B. and Reidenberg, M.M.: Inhibitory effects of gossypol on corticosteroid 11-β-hydroxysteroid dehydrogenase from guinea pig kidney: a possible mechanism for causing hypokalemia. J. Steroid Biochem. Mol. Biol. 39 (1991) 169–176.
Seidman, A.D.: Chemotherapy for advanced breast cancer: a current perspective. Semin. Oncol. 23 (1996) 55–59.
Sidhu, R.S. and Blair, A.H.: Human liver aldehyde dehydrogenase. Esterase activity. J. Biol. Chem. 250 (1975) 7894–7898.
Sladek, N.E.: Oxazaphosphorine-specific acquired cellular resistance. In Teicher, B.A. (Ed.), Drug Resistance in Oncology, Marcel Dekker, N.Y., 1993, pp. 375–411.
Sladek, N.E.: Metabolism and pharmacokinetic behavior of cyclophosphamide and related oxazaphosphorines. In Powis, G. (Ed.), Anticancer Drugs: Reactive Metabolism and Drug Interactions. Pergamon Press, United Kingdom, 1994, pp. 79–156.
Sladek, N.E., Sreerama, L. and Rekha, G.K.: Constitutive and overexpressed human cytosolic class-3 aldehyde dehydrogenases in normal and neoplastic cells/secretions. Adv. Exp. Med. Biol. 372 (1995) 103–114.
Sreerama, L. and Sladek, N.E.: Identification and characterization of a novel class 3 aldehyde dehydrogenase overexpressed in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Biochem. Pharmacol. 45 (1993a) 2487–2505.
Sreerama, L. and Sladek, N.E.: Overexpression or polycyclic aromatic hydrocarbon-mediated induction of an apparently novel class 3 aldehyde dehydrogenase in human breast adenocarcinoma cells and its relationship to oxazaphosphorine-specific acquired resistance. Adv. Exp. Med. Biol. 328 (1993b) 99–113.
Sreerama, L. and Sladek, N.E.: Identification of a methylcholanthrene-induced aldehyde dehydrogenase in a human breast adenocarcinoma cell line exhibiting oxazaphosphorine-specific acquired resistance. Cancer Res. 54 (1994) 2176–2185.
Sreerama, L. and Sladek, N.E.: Human breast adenocarcinoma MCF-7/0 cells electroporated with cytosolic class 3 aldehyde dehydrogenases obtained from tumor cells and a normal tissue exhibit differential sensitivity to mafosfamide. Drug Metab. Dispos. 23 (1995) 1080–1084.
Sreerama, L., Rekha, G.K. and Sladek, N.E.: Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance. Biochem. Pharmacol. 49 (1995) 669–675.
Stein, R.C., Joseph, A.E.A., Matlin, S.A., Cunningham, D.C., Ford, H.T. and Coombes, R.C.: A preliminary clinical study of gossypol in advanced human cancer. Cancer Chemother. Pharmacol. 30 (1992) 480–482.
Tso, W.-W.: Gossypol inhibits Ehrlich ascites tumor cell proliferation. Cancer Lett. 24 (1984) 257–261.
Tuszynski, G.P. and Cossu, G.: Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res. 44 (1984) 766–771.
Wichmann, K., Vaheri, A. and Luukkainen, T.: Inhibiting herpes simplex virus type 2 infection in human epithelial cells by gossypol, a potent spermicidal and contraceptive agent. Am. J. Obstet. Gynecol. 142 (1982) 593–594.
Wilkinson, G.N.: Statistical estimations in enzyme kinetics. Biochem. J. 80 (1961) 324–332.
Wu, D.-F.: An overview of the clinical pharmacology and therapeutic potential of gossypol as a male contraceptive agent and in gynaecological disease. Drugs 38 (1989) 333–341.
Wu, D.-F., Yu, Y.-W., Tang, Z.-M. and Wang, M.-Z.: Pharmacokinetics of (±)-, (+)-, and (-)-gossypol in humans and dogs. Clin. Pharmacol. Ther. 39 (1986) 613–618.
Wu, Y.-W., Chik, C.L. and Knazek, R.A.: An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res. 49 (1989) 3754–3758.
Yao, K.-Q., Gu, Q.-M. and Lei, H.-P.: Effect of (±)-, (+)-and (-)-gossypol on the lactate dehydrogenase-X activity of rat testis. J. Ethnopharmacol. 20 (1987) 25–29.
Yu Y.-W.: Probing into the mechanism of action, metabolism and toxicity of gossypol by studying its (+)-and (-)-sterioisomers. J. Ethnopharmacol. 20 (1987) 65–78.
Zheng, C.-F., Wang, T.T.Y. and Weiner, H.: Cloning and expression of the full-length cDNAs encoding human liver class 1 and class 2 aldehyde dehydrogenase. Alcohol. Clin. Exp. Res. 17 (1993) 828–831.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer Science+Business Media New York
About this chapter
Cite this chapter
Rekha, G.K., Sladek, N.E. (1996). Inhibition of Human Class 3 Aldehyde Dehydrogenase, and Sensitization of Tumor Cells that Express Significant Amounts of this Enzyme to Oxazaphosphorines, by the Naturally Occurring Compound Gossypol. In: Weiner, H., Lindahl, R., Crabb, D.W., Flynn, T.G. (eds) Enzymology and Molecular Biology of Carbonyl Metabolism 6. Advances in Experimental Medicine and Biology, vol 414. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-5871-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-5871-2_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-7692-7
Online ISBN: 978-1-4615-5871-2
eBook Packages: Springer Book Archive